| Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Lancet, The | 2020 | 25.2K |
| Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Lancet, The | 2020 | 15K |
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | American Journal of Respiratory and Critical Care Medicine | 2007 | 5.2K |
| A novel coronavirus outbreak of global health concern | Lancet, The | 2020 | 3.7K |
| A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 | New England Journal of Medicine | 2020 | 3.3K |
| Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations | European Respiratory Journal | 2012 | 2.8K |
| Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial | Lancet, The | 2020 | 2.1K |
| 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study | Lancet, The | 2021 | 1.3K |
| Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia | Journal of Thrombosis and Haemostasis | 2020 | 1K |
| Adherence to continuous positive airway pressure therapy: the challenge to effective treatment | Proceedings of the American Thoracic Society | 2008 | 919 |
| Obesity hypoventilation syndrome: mechanisms and management | American Journal of Respiratory and Critical Care Medicine | 2011 | 706 |
| SARS-CoV-2 and viral sepsis: observations and hypotheses | Lancet, The | 2020 | 646 |
| Asthma | Lancet, The | 2018 | 599 |
| Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids | American Journal of Respiratory and Critical Care Medicine | 1996 | 570 |
| Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study | American Journal of Respiratory and Critical Care Medicine | 2008 | 566 |
| Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study | Lancet, The | 2018 | 525 |
| Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study | Sleep | 2008 | 509 |
| Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans | Proceedings of the National Academy of Sciences of the United States of America | 2002 | 506 |
| A summary of the new GINA strategy: a roadmap to asthma control | European Respiratory Journal | 2015 | 497 |
| Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey | American Journal of Respiratory and Critical Care Medicine | 2007 | 489 |
| Physiology of obesity and effects on lung function | Journal of Applied Physiology | 2010 | 453 |
| Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China | New England Journal of Medicine | 2009 | 441 |
| Airway smooth muscle cell proliferation is increased in asthma | American Journal of Respiratory and Critical Care Medicine | 2001 | 422 |
| Contact investigation for tuberculosis: a systematic review and meta-analysis | European Respiratory Journal | 2013 | 413 |
| On the use of corticosteroids for 2019-nCoV pneumonia | Lancet, The | 2020 | 399 |
